A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma. - Gouda MA; Stephen B; Tian Y; Alshawa A; Onwugaje DOC; Albittar A; Yang Y; Zarifa A; Yilmaz B; Gurses S; Sprenger A; Derbala MH; et al. (Journal of immunotherapy and precision oncology, 2024)